Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Other Operating Expenses (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Other Operating Expenses for 16 consecutive years, with $31059.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses rose 6.11% to $31059.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $115017.0, a 1.48% increase, with the full-year FY2024 number at $110452.0, up 16.78% from a year prior.
  • Other Operating Expenses was $31059.0 for Q3 2025 at Creative Medical Technology Holdings, up from $30742.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $31059.0 in Q3 2025 to a low of $22639.0 in Q4 2024.
  • A 5-year average of $25346.4 and a median of $23021.0 in 2021 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: skyrocketed 39.71% in 2021, then dropped 11.29% in 2024.
  • Creative Medical Technology Holdings' Other Operating Expenses stood at $23021.0 in 2021, then changed by 0.0% to $23021.0 in 2022, then rose by 10.86% to $25521.0 in 2023, then decreased by 11.29% to $22639.0 in 2024, then skyrocketed by 37.19% to $31059.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Other Operating Expenses are $31059.0 (Q3 2025), $30742.0 (Q2 2025), and $30577.0 (Q1 2025).